Live Breaking News & Updates on Zhi hong

Stay informed with the latest breaking news from Zhi hong on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Zhi hong and stay connected to the pulse of your community

Brii punts HIV, depression, lung programs to potential partners

Brii punts HIV, depression, lung programs to potential partners
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

China , Chinese , Zhi-hong , Brii-biosciences , Qpex-biopharma , Brii-bio , Vir-biotechnology , Chinese-yuan ,

Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies

Acquiring all intellectual properties relating to BRII-179 and eliminating future milestone and royalty payments to VBI, subject to achievement of certain...

Hong-kong , Israel , Rehovot , Hamerkaz , United-states , Japan , Beijing , China , Macau , United-kingdom , Canada , Taiwan

VBI Vaccines (VBI) to Sell IP Rights for VBI-2601 to Brii Biosciences

VBI Vaccines (VBI) to Sell IP Rights for VBI-2601 to Brii Biosciences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan , Brii-bio , Prehevbrio-prehevbri , Asia-pacific , Zhi-hong , Vaccines-inc , Nasdaq , Drug-administration , Brii-biosciences , Brii-biosciences-limited , Chief-executive-officer ,

Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer

DURHAM, N.C., and BEIJING, Jan. 3, 2024 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company

Beijing , China , Shanghai , Thailand , Brian-alvin , Briana-johns , Zhi-hong , Brii-biosciences , Brii-bio , Brian-alvin-johns , Hemoshear-therapeutics-inc , Glaxosmithkline

Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure

Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-zealand , Israel , Philippines , Australia , Thailand , Indonesia , Vietnam , Republic-of , Malaysia , Canada , Singapore , South-korea

Brii Biosciences Provides Latest Clinical Development and Corporate Updates

Brii Biosciences Provides Latest Clinical Development and Corporate Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shanghai , China , United-states , United-kingdom , Beijing , South-korea , Singapore , Indonesia , Thailand , Canada , Vietnam , Republic-of

Brii Biosciences Provides Latest Clinical Development And Corporate Updates

Brii Biosciences Provides Latest Clinical Development And Corporate Updates
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Canada , Israel , Indonesia , Shanghai , China , New-zealand , United-kingdom , Philippines , Singapore , Malaysia , Thailand , United-states

VBI Vaccines and Brii Biosciences Expand Hepatitis B Partnership To Address Both Prevention and Treatment in License and Collaboration Agreements for up to $437 Million Plus Royalties

Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri® in the Asia Pacific region

VBI will receive gross proceeds of $15 million in upfront payments, subject to near-term milestone achievements, including an equity investment of approximately $3 million

VBI is eligible to receive up to $422 million in additional potential regulatory and commercial milestone payments, plus double-digit royalties

Canada , Rehovot , Hamerkaz , Israel , Massachusetts , United-states , Cambridge , Cambridgeshire , United-kingdom , Japan , China , Ottawa

Brii Biosciences Provides Latest Clinical Development and Corporate Updates

Brii Biosciences Provides Latest Clinical Development and Corporate Updates
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , New-zealand , Beijing , China , Philippines , Thailand , Vietnam , Republic-of , Malaysia , Singapore , South-korea , Canada

Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure

/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," "we," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve...

United-kingdom , Beijing , China , Philippines , New-zealand , Thailand , Vietnam , Republic-of , South-korea , Malaysia , Singapore , United-states